Cryptococcus neoformans evades pulmonary immunity by modulating xylose precursor transport
L. X. Li, C. R. Hole, J. Rangel-Moreno, S. A. Khader, T. L. Doering
Abstract
Cryptococcus neoformans is a fungal pathogen that kills almost 200,000 people each year and is distinguished by abundant and unique surface glycan structures that are rich in xylose. A mutant strain of C. neoformans that cannot transport xylose precursors into the secretory compartment is severely attenuated in virulence in mice, yet surprisingly is not cleared. We found that this strain failed to induce the non-protective T helper cell type 2 (Th2) responses characteristic of wild-type infection, instead promoting sustained Interleukin (IL)-12p40 induction and increased IL-17A (IL-17) production. It also stimulated dendritic cells to release high levels of pro-inflammatory cytokines, a behavior we linked to xylose expression. We further discovered that inducible bronchus associated lymphoid tissue (iBALT) forms in response to infection with either wild-type cryptococci or the mutant strain with reduced surface xylose; although iBALT formation is slowed in the latter case, the tissue is better organized. Finally, our temporal studies suggest that lymphoid structures in the lung restrict the spread of mutant fungi for at least 18 weeks after infection, in contrast to ineffective control of the pathogen after infection with wild-type cells. These studies demonstrate the role of xylose in modulation of host response to a fungal pathogen and show that cryptococcal infection triggers iBALT formation.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Polyphosphate mobilization influences the ability of Cryptococcus neoformans to cause disease in a murine model of cryptococcosis
Kabir Bhalla, Eddy Sánchez‐León, … James W. Kronstad·Infection and ImmunityPeer-reviewed·Mar 12, 2025
- Cryptococcus neoformans secretes small molecules that inhibit IL-1β inflammasome-dependent secretion
P. H. Bürgel, C. L. Marina, … A. Bocca·bioRxiv·Feb 19, 2019
- Interleukin-17A Secreted from the Lung-infiltrating T Helper 17 Cells Renders Protective Immunity to Pulmonary Cryptococcus neoformans Infection
Elaheh Movahed, Grace Min Yi Tan, … Chung Yeng Looi·bioRxiv·May 23, 2018
- Neutrophils Restrain CCR2-Dependent Monocyte Immunopathology During Pulmonary Cryptococcosis.
Mikayla C Harden-Pruitt, Rebekah G Rebekah, Camaron R. Hole·bioRxiv·Oct 27, 2026
- Global proteomic analysis of Cryptococcus neoformans clinical strains reveals significant differences between latent and lethal infection
Jovany Jordan Betancourt, Jason A. McAlister, … Kirsten Nielsen·mSystemsPeer-reviewed·Sep 25, 2025
- Regulated release of cryptococcal polysaccharide drives virulence and suppresses immune cell infiltration into the central nervous system
S. T. Denham, S. Verma, … J. C. S. Brown·bioRxiv·Sep 10, 2017